No new Alzheimer's drug treatment had be licensed for 20 years until 2021, when the first Alzheimer's disease-modifying therapy (DMT) was licensed in the USA, giving hope of slowing/reversing the disease. Several new DMTs are expected. Unfortunately, offering DMTs in Ireland requires significant changes in Memory Clinic set-up, due to high drug costs and need for careful monitoring. Moreover, DMTs only work in people in early Alzheimer's, which is often unrecognized in Ireland. Thus, to ensure our health system is DMT ready, we will survey Irish residents and healthcare professionals regarding their perspectives on DMTs, since public views are critical to health developments.
Field of research
Principal Investigator/ Researcher Names
Professor Iracema Leroi
Professor Sean Kennelly
Professor Suzanne Timmons
Dr Irina Kinchin
Dr Ann Nolan
Alzheimer Society of Ireland - Dr Laura O'Philbin
HRB-CTN Dementia Trials Ireland - Laura Gibney
National Dementia Office - Dr Emer Begley
Global Brain Health Institute (GBHI) - Dr Sean O’Dowd
Institution
Start date
Project completed
No
End/expected end date
Project ongoing
No
Funding body
Irish Research Council
Are you looking to Recruit Research Participants?
No
Papers published: